 |
Market Cap | 8.46B | EPS (ttm) | 0.26 |
P/E | 644.64 | EPS this Y | -9.37% |
Forward P/E | 16.10 | EPS next Y | 9.83% |
PEG | 187.94 | EPS past 5Y | -47.65% |
P/S | 2.09 | EPS next 5Y | 3.43% |
P/B | 2.44 | EPS Q/Q | -216.39% |
Dividend | - | Sales Q/Q | -1.08% |
Insider Own | 1.12% | Inst Own | 105.01% |
Insider Trans | -0.77% | Inst Trans | 1.90% |
Short Float | 5.80% | Earnings | Feb 19/b |
Analyst Recom | 2.90 | Target Price | 174.87 |
Avg Volume | 1.12M | 52W Range | 150.79 - 274.77 |
|
|
Today | Downgrade |
Goldman |
Buy → Neutral |
$190 → $170 |
|
|
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
FOSTER JAMES C | Chairman, President and CEO | Feb 20 '25 | Buy | 165.01 | 6,075 | 1,002,436 | 183,639 | Feb 21 04:41 PM | Girshick Birgit | Corporate Executive VP & COO | Feb 20 '25 | Buy | 164.63 | 1,514 | 249,250 | 55,058 | Feb 21 04:38 PM | LaPlume Joseph W | EVP, Corp Strategy & Develop | Feb 20 '25 | Sale | 162.50 | 4,400 | 715,000 | 20,013 | Feb 21 04:36 PM | Joseph LaPlume | Officer | Feb 20 '25 | Proposed Sale | 165.00 | 4,400 | 726,000 | | Feb 20 12:36 PM | WALLMAN RICHARD F | Director | Nov 07 '24 | Sale | 216.12 | 6,621 | 1,430,918 | 12,386 | Nov 12 04:38 PM |
|
|
 |
 |
Market Cap | 16.46M | EPS (ttm) | -0.80 |
P/E | - | EPS this Y | 13.94% |
Forward P/E | - | EPS next Y | 0.82% |
PEG | - | EPS past 5Y | -25.69% |
P/S | - | EPS next 5Y | 1.36% |
P/B | 0.27 | EPS Q/Q | 5.21% |
Dividend | - | Sales Q/Q | - |
Insider Own | 12.07% | Inst Own | 56.02% |
Insider Trans | 0.00% | Inst Trans | -25.33% |
Short Float | 16.43% | Earnings | Mar 06/a |
Analyst Recom | 2.00 | Target Price | 1.86 |
Avg Volume | 2.49M | 52W Range | 0.41 - 5.83 |
|
|
Today | Downgrade |
Piper Sandler |
Overweight → Neutral |
$0.70 |
Today | Downgrade |
Citizens JMP |
Mkt Outperform → Mkt Perform |
|
Today | Downgrade |
Leerink Partners |
Outperform → Market Perform |
$1 |
|
|
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm's program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA. |
|
 |
 |
Market Cap | 16.39B | EPS (ttm) | 13.96 |
P/E | 30.87 | EPS this Y | 3.94% |
Forward P/E | 23.40 | EPS next Y | 7.71% |
PEG | 4.68 | EPS past 5Y | 8.91% |
P/S | 7.35 | EPS next 5Y | 6.60% |
P/B | 8.23 | EPS Q/Q | 1.32% |
Dividend | 0.98% | Sales Q/Q | 4.88% |
Insider Own | 0.24% | Inst Own | 95.75% |
Insider Trans | -34.29% | Inst Trans | 0.43% |
Short Float | 4.30% | Earnings | Mar 20/b |
Analyst Recom | 3.33 | Target Price | 457.94 |
Avg Volume | 280.61K | 52W Range | 391.84 - 499.87 |
|
|
Today | Downgrade |
Wells Fargo |
Equal Weight → Underweight |
$402 |
|
|
FactSet Research Systems Inc. (the Company or FactSet) is a global financial digital platform and enterprise solutions provider with open and flexible technologies that aims to supercharge financial intelligence. Since inception, global financial professionals have utilized the company's content and multi-asset class solutions across each stage of the investment process. FactSet's goal is to provide a seamless user experience spanning idea generation, research, portfolio construction, trade execution, performance measurement, risk management, reporting, and portfolio analysis, in which the company serves the front, middle, and back offices to drive productivity and improved performance. FactSet's flexible, open data and technology solutions can be implemented both across the investment portfolio lifecycle or as standalone components serving different workflows in the organization. FactSet is focused on growing the business throughout each of its three segments, the Americas, EMEA (formerly known as Europe), and Asia Pacific. FactSet revised its internal organization within each segment to offer data, products and analytical applications by firm type: Institutional Buyside, Dealmakers, Wealth, and Partnerships and CGS. The company believes organization by firm type better aligns with its clients, the long-term view of its business and commitment to investing for growth and efficiency. FactSet currently serves financial professionals, which include portfolio managers, investment research professionals, investment bankers, risk and performance analysts, wealth advisors and corporate clients. FactSet provides both insights on global market trends and intelligence on companies and industries, as well as capabilities to monitor portfolio risk and performance and to execute trades. The company combines dedicated client service with open and flexible technology offerings, such as a configurable desktop and mobile platform, comprehensive data feeds, an open marketplace and digital portals and application programming interfaces (APIs). The company's revenue is primarily derived from subscriptions to products and services such as workstations, analytics, enterprise data, and research management. FactSet Research Systems was founded by Howard E. Wille and Charles J. Snyder in September 1978 and is headquartered in Norwalk, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Snow Frederick Philip | Chief Executive Officer | Mar 03 '25 | Option Exercise | 152.28 | 3,000 | 456,840 | 19,616 | Mar 03 04:29 PM | Snow Frederick Philip | Chief Executive Officer | Mar 03 '25 | Sale | 464.79 | 3,000 | 1,394,370 | 16,616 | Mar 03 04:29 PM | Snow Frederick Philip | Chief Executive Officer | Feb 03 '25 | Option Exercise | 152.28 | 3,000 | 456,840 | 19,616 | Feb 03 05:15 PM | Snow Frederick Philip | Chief Executive Officer | Feb 03 '25 | Sale | 469.14 | 3,000 | 1,407,420 | 16,616 | Feb 03 05:15 PM | Snow Frederick Philip | Chief Executive Officer | Jan 02 '25 | Option Exercise | 152.28 | 3,000 | 456,840 | 19,616 | Jan 03 04:42 PM |
|
|
|  |
 |
Market Cap | 59.30B | EPS (ttm) | 15.69 |
P/E | 15.70 | EPS this Y | 3.69% |
Forward P/E | 11.76 | EPS next Y | 13.45% |
PEG | 1.62 | EPS past 5Y | 53.32% |
P/S | 0.68 | EPS next 5Y | 9.70% |
P/B | 2.24 | EPS Q/Q | -14.67% |
Dividend | 2.22% | Sales Q/Q | -0.89% |
Insider Own | 8.50% | Inst Own | 77.70% |
Insider Trans | -0.03% | Inst Trans | -1.35% |
Short Float | 1.64% | Earnings | Mar 20/a |
Analyst Recom | 2.03 | Target Price | 299.50 |
Avg Volume | 1.69M | 52W Range | 239.50 - 313.84 |
|
|
Today | Downgrade |
Loop Capital |
Hold → Sell |
$221 |
Today | Reiterated |
TD Cowen |
Buy |
$337 → $310 |
|
Today 09:08AM
|
Stocks watch tariffs, Nike & FedEx, Heathrow fire: 3 Things
(Yahoo Finance Video) |
09:03AM
|
The vast majority of FedEx's guidance cut is a macro problem: Evercore ISI's Jonathan Chappell
(CNBC TV) |
08:55AM
|
Q3 2025 FedEx Corp Earnings Call
(Thomson Reuters StreetEvents) |
08:25AM
|
These Stocks Are Moving the Most Today: FedEx, Nike, Micron, NIO, Lennar, Quantum Computing, Super Micro, and More
(Barrons.com) |
08:15AM
|
FedEx Stock Tumbles After Earnings. Why It Got Downgraded to Sell.
(Barrons.com) |
08:03AM
|
Rosa: FedEx is a cheap stock, but patience is needed
(CNBC TV) |
07:58AM
|
5 Things to Know Before the Stock Market Opens
(Investopedia) |
07:47AM
|
Nvidia, Micron, Nike, Nio, Carnival, FedEx: Stocks to watch today
(Quartz) |
06:29AM
|
Futures slip on tariff woes; FedEx falls on bleak forecast
(Reuters) |
05:36AM
|
FedEx shares slide as annual forecast cuts stoke worries on economy
(Reuters) |
|
FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Ground, FedEx Freight, FedEx Services, and Corporate, Other and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Ground segment provides small-package ground delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SCHWAB SUSAN C | Director | Jan 14 '25 | Option Exercise | 174.63 | 3,980 | 695,047 | 12,884 | Jan 14 05:17 PM | SCHWAB SUSAN C | Director | Jan 14 '25 | Sale | 276.45 | 3,980 | 1,100,257 | 8,904 | Jan 14 05:17 PM | SCHWAB SUSAN C | Director | Jan 14 '25 | Proposed Sale | 274.59 | 3,980 | 1,092,868 | | Jan 14 05:04 PM | Smith Richard W | COO INTL - CEO Airline FEC | Jan 07 '25 | Option Exercise | 180.82 | 3,220 | 582,240 | 114,462 | Jan 10 04:31 PM | Smith Richard W | COO INTL - CEO Airline FEC | Jan 07 '25 | Sale | 276.93 | 2,576 | 713,373 | 111,886 | Jan 10 04:31 PM |
|
|
 |
 |
Market Cap | 14.86B | EPS (ttm) | 9.54 |
P/E | 19.29 | EPS this Y | -0.78% |
Forward P/E | 11.74 | EPS next Y | 12.85% |
PEG | 2.53 | EPS past 5Y | 6.54% |
P/S | 1.79 | EPS next 5Y | 7.63% |
P/B | 1.56 | EPS Q/Q | 21.42% |
Dividend | - | Sales Q/Q | -1.22% |
Insider Own | 0.70% | Inst Own | 96.78% |
Insider Trans | 0.00% | Inst Trans | -3.01% |
Short Float | 2.10% | Earnings | Feb 19/a |
Analyst Recom | 1.50 | Target Price | 245.53 |
Avg Volume | 932.73K | 52W Range | 174.93 - 347.72 |
|
|
Today | Downgrade |
Goldman |
Buy → Neutral |
$250 → $200 |
|
|
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
RONAN MARTIN MURPHY | Officer | Mar 17 '25 | Proposed Sale | 187.07 | 1,540 | 288,082 | | Mar 17 04:33 PM | THOMAS NOEL O LEARY | Officer | Mar 04 '25 | Proposed Sale | 182.43 | 796 | 145,214 | | Mar 04 05:24 PM | DIARMAID CUNNINGHAM | Officer | Mar 04 '25 | Proposed Sale | 182.43 | 1,185 | 216,180 | | Mar 04 05:23 PM | BARRY EDWARD BALFE | Officer | Mar 04 '25 | Proposed Sale | 182.43 | 1,216 | 221,835 | | Mar 04 05:20 PM | STEPHEN CUTLER | Officer | Mar 04 '25 | Proposed Sale | 182.43 | 5,496 | 1,002,635 | | Mar 04 05:18 PM |
|
|
|  |
 |
Market Cap | 181.82B | EPS (ttm) | 10.56 |
P/E | 12.40 | EPS this Y | 5.41% |
Forward P/E | 8.93 | EPS next Y | 21.90% |
PEG | 0.89 | EPS past 5Y | - |
P/S | 3.32 | EPS next 5Y | 14.00% |
P/B | 4.58 | EPS Q/Q | 17.64% |
Dividend | - | Sales Q/Q | 25.13% |
Insider Own | 2.71% | Inst Own | 27.20% |
Insider Trans | 0.00% | Inst Trans | -6.00% |
Short Float | 1.69% | Earnings | Mar 20/b |
Analyst Recom | 1.61 | Target Price | 152.50 |
Avg Volume | 8.91M | 52W Range | 88.01 - 164.69 |
|
|
Today | Downgrade |
Nomura |
Buy → Neutral |
$137 → $130 |
|
|
PDD Holdings, Inc. is a multinational commerce group that owns and operates a portfolio of businesses. The company aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from increased productivity and new opportunities. It has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses. PDD Holdings was founded by Hua Lin Cai and Zheng Huang in 2015 and is headquartered in Dublin, Ireland. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Zhao Jiazhen | Officer | Dec 30 '24 | Proposed Sale | 97.45 | 40,000 | 3,898,000 | | Dec 30 06:11 AM | Zhao Jiazhen | Officer | Dec 09 '24 | Proposed Sale | 99.89 | 16 | 1,598 | | Dec 09 06:22 AM | Kam Anthony Ping Leung | Director | Sep 25 '24 | Proposed Sale | 113.80 | 2,343 | 266,633 | | Sep 25 06:27 AM |
|
|
 |
 |
Market Cap | 1.36B | EPS (ttm) | 0.27 |
P/E | 32.66 | EPS this Y | -44.33% |
Forward P/E | 46.10 | EPS next Y | 28.17% |
PEG | - | EPS past 5Y | -14.29% |
P/S | 0.99 | EPS next 5Y | - |
P/B | 0.71 | EPS Q/Q | -175.00% |
Dividend | 6.76% | Sales Q/Q | 3.22% |
Insider Own | 2.83% | Inst Own | 98.00% |
Insider Trans | 0.23% | Inst Trans | 5.46% |
Short Float | 8.72% | Earnings | Feb 25/a |
Analyst Recom | 3.00 | Target Price | 11.22 |
Avg Volume | 1.78M | 52W Range | 8.45 - 12.11 |
|
|
Today | Downgrade |
Truist |
Buy → Hold |
$11 → $10 |
|
|
RLJ Lodging Trust is a real estate investment trust, which engages in the ownership and acquisition of hotels. It operates through the following hotel brands: Embassy Suites, Marriott, Hilton, Hyatt House, Hyatt Place, Hilton Garden Inn, Wyndham, Renaissance, Fairfield Inn & Suites, Holiday Inn Express, Sleep Inn, Hampton Inn, Hotel Indigo, IHG, SpringHill Suites, Hyatt Centric, and Homewood Suites. The company was founded by Robert L. Johnson on January 31, 2011 and is headquartered in Bethesda, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gibson Patricia L | Director | Mar 07 '25 | Buy | 9.38 | 10,000 | 93,783 | 114,217 | Mar 10 04:36 PM |
|
|
|  |
 |
Market Cap | 92.17M | EPS (ttm) | -1.69 |
P/E | - | EPS this Y | 54.14% |
Forward P/E | - | EPS next Y | 51.64% |
PEG | - | EPS past 5Y | 5.17% |
P/S | 1.34 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 6.17% |
Dividend | - | Sales Q/Q | 25.94% |
Insider Own | 19.65% | Inst Own | 61.76% |
Insider Trans | 2.41% | Inst Trans | 270.99% |
Short Float | 1.48% | Earnings | Mar 20/a |
Analyst Recom | 1.40 | Target Price | 6.20 |
Avg Volume | 145.68K | 52W Range | 2.18 - 6.50 |
|
|
Today | Downgrade |
Piper Sandler |
Overweight → Neutral |
$5 → $2 |
|
|
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Cuca Roberto | COO and CFO | Oct 24 '24 | Buy | 2.25 | 64,444 | 144,999 | 155,388 | Oct 24 04:26 PM | Talmo Paul | Chief Technology Officer | Oct 24 '24 | Buy | 2.25 | 22,222 | 50,000 | 91,082 | Oct 24 04:25 PM | KOBLISH ANTONY | Chief Executive Officer | Oct 24 '24 | Buy | 2.25 | 88,888 | 199,998 | 458,897 | Oct 24 04:25 PM | Firestone Gregory A. | Chief Commercial Officer | Oct 24 '24 | Buy | 2.25 | 6,666 | 14,998 | 57,279 | Oct 24 04:24 PM | ORBIMED ADVISORS LLC | 10% Owner | Jun 28 '24 | Sale | 4.74 | 378,000 | 1,791,720 | 2,457,542 | Jul 02 04:54 PM |
|
|
 |
 |
Market Cap | 22.18B | EPS (ttm) | 0.48 |
P/E | 30.32 | EPS this Y | -2.42% |
Forward P/E | 18.46 | EPS next Y | 11.24% |
PEG | 3.83 | EPS past 5Y | -14.92% |
P/S | 1.51 | EPS next 5Y | 7.91% |
P/B | 2.03 | EPS Q/Q | 18.19% |
Dividend | 7.97% | Sales Q/Q | 0.70% |
Insider Own | 0.14% | Inst Own | 57.39% |
Insider Trans | 0.00% | Inst Trans | 2.78% |
Short Float | 2.59% | Earnings | Feb 13/b |
Analyst Recom | 2.26 | Target Price | 15.97 |
Avg Volume | 3.69M | 52W Range | 13.24 - 17.26 |
|
|
Today | Downgrade |
BofA Securities |
Buy → Neutral |
|
|
|
TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences-TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada. |
|
 |
 |
Market Cap | 6.55B | EPS (ttm) | 17.19 |
P/E | 19.00 | EPS this Y | 5.83% |
Forward P/E | 16.38 | EPS next Y | 9.63% |
PEG | 2.04 | EPS past 5Y | 20.64% |
P/S | 1.61 | EPS next 5Y | 9.32% |
P/B | 4.24 | EPS Q/Q | 122.00% |
Dividend | 0.83% | Sales Q/Q | 2.14% |
Insider Own | 1.60% | Inst Own | 90.12% |
Insider Trans | -13.29% | Inst Trans | -0.86% |
Short Float | 2.24% | Earnings | Feb 18/b |
Analyst Recom | 2.29 | Target Price | 406.50 |
Avg Volume | 125.79K | 52W Range | 202.01 - 379.22 |
|
|
Today | Downgrade |
William Blair |
Outperform → Mkt Perform |
|
|
|
Valmont Industries, Inc. engages in the manufacture of products and services for infrastructure and agriculture markets. It operates through the Infrastructure and Agriculture segments. The Infrastructure segment includes five primary product lines such as Transmission, Distribution, and Substation, Lighting and Transportation, Coatings, Telecommunications, and Renewable Energy. The Agriculture segment produces mechanized irrigation equipment and related services. The company was founded by Robert B. Daugherty in 1946 and is headquartered in Omaha, NE. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Freye Theodor Werner | Director | Feb 25 '25 | Sale | 348.00 | 1,000 | 348,000 | 2,685 | Feb 26 04:02 PM | Freye Theodor Werner | Director | Feb 25 '25 | Proposed Sale | 348.00 | 1,000 | 348,000 | | Feb 25 02:05 PM | Larkin Diane M | EVP, Global Operations | Feb 19 '25 | Option Exercise | 225.50 | 6,267 | 1,413,188 | 9,806 | Feb 21 04:09 PM | Larkin Diane M | EVP, Global Operations | Feb 19 '25 | Sale | 373.36 | 3,133 | 1,169,749 | 7,524 | Feb 21 04:09 PM | Larkin Diane M | Officer | Feb 19 '25 | Proposed Sale | 373.36 | 3,133 | 1,169,751 | | Feb 19 12:05 PM |
|
|
|